Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk. Atherosclerosis. 2010 Nov; 213(1):1-7.